Download in electronic PDF format for $25



Search the Complete Journal Archives

Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, dapsone, oral suspension, leprosy, pneumocystis pneumonia, dermatitis herpetiformis

Related Categories: DERMATOLOGY, FORMULATIONS, INFECTIOUS DISEASE, RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr Nov/Dec 2017 491 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr Jul/Aug 2006 300 Buy
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D May/Jun 2003 233-239 Buy
Pediatric Dermatitis Remmert Renee Nov/Dec 2002 419-421 Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9 Buy
Dapsone 5% Topical Gel Allen Loyd V Jr Nov/Dec 2011 502 Buy
Women's Oral Health: Is There a Hormonal Link? Preckshot John Jan/Feb 2004 10 Buy
Basics of Compounding for Cough Allen Loyd V Jr Nov/Dec 2004 462-465 Buy
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Allen Loyd V Jr Mar/Apr 2010 151 Buy